Every baby born in the U.S. receives a state-mandated newborn screening (NBS). This public health program is a critical first line of defense to catch certain serious but treatable conditions before they cause harm. But it’s just the beginning of what’s possible with modern genomics.
At a Glance: State Newborn Screening vs. Fore Genomics
| State Newborn Screening (NBS) | Fore Genomics | |
|---|---|---|
| Conditions covered | 30–60 (varies by state) | ~1,000 genes/conditions |
| When it’s done | 24–48 hours after birth, one time | Any age, with annual reanalysis |
| Method | Heel-prick blood + hearing + pulse oximetry | At-home cheek swab |
| Focus | Life-threatening newborn disorders | Childhood-onset conditions, carrier status, medication response |
| Stays current? | One-time snapshot | Re-interpreted yearly as science evolves |
| Access | Automatic, no parent action | Ordered by the family, no clinic visit |
What State-Mandated Newborn Screening (NBS) Does
The basics:
- Required by law in every state (with rare exceptions)
- Performed early: usually within 24–48 hours after birth
- Method: heel-prick blood test + hearing screen + pulse oximetry
- Scope: 30–60 conditions (varies by state) — focused on a few dozen life-threatening but treatable newborn disorders
What NBS does well
- Saves lives. It catches certain critical disorders before symptoms appear.
- Universal coverage. Every newborn gets screened — no action required from parents.
- Reliable results. State labs are highly standardized and quality-controlled.
The Limits of NBS
State screening is excellent, but narrow:
- Limited scope: Screens for just 30–60 conditions out of thousands known to affect children.
- One-time snapshot: No ongoing updates as science advances.
- No medication insights: Offers no pharmacogenomic information about how a child might react to common medicines.
- Misses later-onset disorders: Conditions that appear in toddlerhood, childhood, or adolescence aren’t covered.
Put simply: NBS is a strong safety net — but it was never meant to give parents the full genetic picture.
How Fore Genomics Goes Further
Fore Genomics was built to fill those gaps and give families more power to plan ahead.
Where Fore leads:
- Comprehensive panel: ~1,000 genes/conditions — far beyond the state’s 30–60.
- Broader coverage: Includes childhood-onset diseases, carrier status, and medication response insights.
- Any-age testing: Available beyond the newborn period — toddler, school-age, even adulthood.
- At-home convenience: Simple cheek swab, no hospital visit required.
- Annual reanalysis: Your child’s DNA is re-interpreted every year as science evolves — without retesting.
- Actionable planning: Reports are designed to help families and physicians act early, not just react.
Why Parents Choose Both
Think of state NBS as the minimum standard of care — vital, but limited. Fore Genomics builds on that foundation to provide:
- Peace of mind: You’re not relying only on what the state tests today.
- Future-proofing: Your child’s genetics are reanalyzed as new discoveries are made.
- Personalized guidance: Helps inform medical decisions and prevent future emergencies.
For parents who want the most complete, proactive view of their child’s health, combining state NBS with Fore Genomics is the smartest approach.
FAQs
Does Fore Genomics replace my state’s newborn screening?
No. State newborn screening is required and valuable, and every baby should have it. Fore Genomics is designed to complement it — screening for about 1,000 conditions beyond the state’s 30–60, and adding insights that newborn screening doesn’t cover.
How many conditions does state newborn screening cover?
Typically 30 to 60, and the exact list varies by state. It focuses on serious but treatable disorders that benefit from being caught in the first days of life.
Can I use Fore Genomics if my child is no longer a newborn?
Yes. Unlike state screening, which is a one-time newborn test, Fore Genomics can be done at any age and re-analyzes your child’s DNA each year as new discoveries are made.